Morgan Stanley lowered the firm’s price target on Endava (DAVA) to $11 from $17 and keeps an Equal Weight rating on the shares. While “encouraged” by Endava’s Gen AI investments and expanding partner ecosystem, the company’s FY26 growth forecast of (1.5) to up 0.5% year-over-year in constant currency suggests “a transitional year” and near-term margin pressure is likely to overshadow long-term benefits, the analyst tells investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAVA:
- Endava price target lowered to $11 from $14 at Deutsche Bank
- Endava price target lowered at Guggenheim, removed as ‘Best Idea’
- Endava Reports Strong Financial Growth Amid Market Expansion
- Endava’s Earnings Call: Mixed Sentiment Amid Achievements and Challenges
- Endava’s Strategic Overhaul Amid Market Challenges: Hold Rating Maintained